Data + Perspectives: The Current and Future Role of Immune
Checkpoint Inhibitors and Other Novel Therapies in the Management
of Gynecologic Cancers — Interview with Dr O’Malley on the
following topics:
Emerging efficacy and safety data with and ongoing
investigation of tisotumab vedotin in the management of gynecologic
cancers (00:00)
Dual ICI combination regimens under investigation for
gynecologic cancers (3:50)
Clinical care of patients with HER2-positive endometrial cancer
(8:39)
Efficacy and tolerability of pembrolizumab/lenvatinib in
patients with microsatellite-stable endometrial cancer (12:01)
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.